Auto saved by Logseq

journals/2024_04_04.md

@@ -51,7 +51,9 @@
 			- Y por último Sanger working on developing surveillance methods por genomic ana
 			- The target of the consorcios es crear goals and evidence needed by WHO in evaluating the incorporating this strategies  into programs.
 			- We know that the FDC también es util para oncho, lf, scabies y demás pero tenemos que elegir una disease of particular interest to perform the particular studies. So far the achievements have been: submission to EMA through art 58. the main target is leading the way to prequalification to WHO. We did the pivotal trial that demonstrated safety efficacy against T. Trichiura.
-			-
+			- Our current main challenges are safety and acceptability. We've had conversations with the department in Geneva to align our strategies.
+			- Evaluation of implementation strategies, pathways to programs and an access plan.
+			- We look for your interes
 			-
 -
 - ## Cosas de gastos del [[Evento]]